Cannabis extractor
MediPharm Labs Corp. (
TSX.LABS) announced it has begun shipping its cannabis-infused topical products via a contract manufacturing agreement.
Specifics regarding the size of the shipment were not disclosed, but the company said it is ramping research efforts to create base compounds which will eventually be used for cannabis topicals.
The announcement comes one day after MediPharm said it
shipped a large shipment of cannabis extract and 35,000 units of finished products for the Australian market.
Full press release
here.